Table 3 Characteristics of HHV-6 DNA positive patients. Nota Bene 2017 Change of WHO T-Staging system depending on tumor size
Gender | Age distribution | Localization | Grading | Stage (NB 2017 WHO change) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M: 26 | F: 24 | 46—83 | caput: 43 | Corpus:1 | cauda:5 | unclear/different areas: 1 | no grading (after chemotherapy): 1 | G2:29 | G3: 20 | pT1: 2 | pT2: 8 | pT3: 38 (inlc. one case ypT3) | pT4: 2 |